No Data
No Data
Express News | Scynexis Inc - Cash Runway Exceeds Two Years
Express News | Scynexis : GSK Will Also Pay Mid-Single Digit to Mid-Teen Digit Tiered Royalties on Totality of Ibrexafungerp Sales Across All Indications
Express News | Scynexis Inc - Milestone Payment Triggered by Clinical Study Reports
Express News | Scynexis : Eligible for Additional $323 Million in Milestone Payments
Express News | Scynexis to Receive $10 Million Milestone Payment From GSK Triggered by Delivery of Completed Furi, Cares and Nature Clinical Study Reports
Buy Rating Affirmed for Scynexis on Robust Financials and Promising Antifungal Pipeline
TrytosaveabitOP : Scynexis : GSK Will Also Pay Mid-Single Digit to Mid-Teen Digit Tiered Royalties on Totality of Ibrexafungerp Sales Across All Indications